Correlation Between Tcr2 Therapeutics and Day One
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Tcr2 Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Day One.
Diversification Opportunities for Tcr2 Therapeutics and Day One
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tcr2 and Day is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Day One go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Day One
If you would invest (100.00) in Tcr2 Therapeutics on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Tcr2 Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Tcr2 Therapeutics vs. Day One Biopharmaceuticals
Performance |
Timeline |
Tcr2 Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Day One Biopharmaceu |
Tcr2 Therapeutics and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tcr2 Therapeutics and Day One
The main advantage of trading using opposite Tcr2 Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc | Tcr2 Therapeutics vs. Revolution Medicines |
Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |